INTRODUCTION
NAC (nascent polypeptide-associated complex) is a heterodimeric protein complex consisting of a 33 kDa α and a 21 kDa β subunit. It was identified in 1994 by Wiedmann et al. [1] , and plays a role in regulating assembly and targeting of nascent polypeptide chains just emerging from the ribosome (for a review see [2] ).
skNAC (skeletal and heart muscle specific variant of αNAC) is generated by splicing-in of a large additional exon in between the αNAC-specific N-and C-terminal coding regions, thus generating a large 220 kDa proline-rich protein [3] , which is exclusively found in the striated muscle tissue of skeletal muscle and the heart.
The function of skNAC is still largely unknown. Yotov and St.-Arnaud [3] showed that the protein may act as a muscle-specific transcriptional co-activator, thus stimulating transcription of the myoglobin gene. Correspondingly, skNAC gene-deficient mice are characterized by decreased myoglobin gene expression and the loss of red muscle fibres, thus suggesting a role of skNAC in activating the transcription of genes characteristic for the oxidative muscle fibre phenotype [4] . A function for skNAC in transcriptional regulation is also suggested by the fact that the protein interacts with m-Bop/Smyd1 (SET and MYND domaincontaining protein 1), a histone methyltransferase essential for cardiogenesis [5] . However, the fact that both skNAC and mBop/Smyd1 undergo nuclear-to-cytoplasmic translocation during myogenic differentiation [5] suggests that the proteins might also play a role in the cytosol. In fact, in a zebrafish model system, Li et al. [6] showed that depletion of skNAC leads to non-functional disorganized sarcomeres, which are specifically characterized by misaligned actin and myosin filaments, a feature that had previously also been demonstrated for m-Bop/Smyd1 in the same model system [7] .
In a mammalian system of cultured murine myoblasts in which expression of the skNAC gene had been knocked down, we demonstrated recently that perturbed sarcomere architecture specifically disorganized actin and myosin filaments [8] , suggesting that, similarly to the zebrafish model, skNAC is an organizer of actin and myosin incorporation into newly forming sarcomeres in mammalian cells; however, its mechanism of action is still unknown. Whereas the localization of skNAC in the cytosol during later stages of the differentiation process [5, 6] , and the localization of the skNAC-binding partner m-Bop/Smyd1 even within the sarcomeres themselves [9, 10] , suggests direct involvement of the proteins in actin and/or myosin protein turnover, it is also possible that, via their potential function as transcriptional regulators, they might control downstream targets which then regulate sarcomere development and/or maintenance.
In search of such downstream targets, we hypothesized that skNAC might regulate the function of calpains, a family of cytosolic Ca 2 + -dependent cysteine proteases, consisting of the ubiquitous calpains 1 and 2, and calpain 3, which is mainly present in skeletal muscle tissue (for a review see [11] ). Our hypothesis of a potential link between skNAC and calpains arose mainly from the fact that calpain 3, at least, is known to be a central regulator of sarcomere assembly, turnover and maintenance, which is impressively illustrated by the fact that mutations in this gene cause the human disease LGMD2a (limb girdle muscular dystrophy type 2A) (for a review see [12] ).
In the present study, we demonstrate that the repression of skNAC gene expression in skeletal muscle cells results in strongly enhanced expression of the calpains 1 and 3 genes leading to induced enzymatic activity, whereas overexpression of the skNAC gene in the same cells had the opposite effect. Interestingly, corresponding to the fact that elevated calpain activity is known to result in enhanced myoblast migration [13, 14] , skNAC Abbreviations used: ALLN, N-acetyl-leucyl-leucyl-norleucinal; LGMD2a, limb girdle muscular dystrophy type 2A; MARCKS, myristoylated alanine-rich Ckinase substrate; MyHC, myosin heavy chain; NAC, nascent polypeptide-associated complex; qPCR, quantitative real time PCR; RT, reverse transcription; skNAC, skeletal and heart muscle specific variant of αNAC; Smyd1, SET and MYND domain-containing protein 1.
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gene-knockdown cells were characterized by significantly higher migration rates, accompanied by enhanced cleavage of the calpain substrate MARCKS (myristoylated alanine-rich C-kinase substrate), a PKC (protein kinase C) substrate localized at focal adhesions and known to be involved in the regulation of actin stress fibre formation and myoblast migration [15] . Increased calpain activity was also associated with altered patterns of myosin distribution within the cell, indicating perturbed sarcomere architecture. Both the effects of the skNAC gene knockdown on myoblast migration and on sarcomere architecture could be blocked by the calpain inhibitor ALLN (N-acetyl-leucylleucyl-norleucinal), suggesting that they are indeed mediated by elevated calpain activity.
The results of the present study thus provide a mechanistic basis for the regulation of myoblast migration and sarcomere architecture by skNAC.
MATERIALS AND METHODS

Tissue culture
Murine C2C12 cells were cultured in DMEM containing 20 % FBS (growth medium) at 37
• C and 5% CO 2 . To induce differentiation, cells were grown to 80-90 % confluency and then switched to differentiation medium (DMEM containing 2 % horse serum). The calpain inhibitor ALLN (50 μM) was added 48 h after the induction of differentiation and cells were then fixed for immunofluorescence analysis after a total of 96 h. For the migration and adhesion assays using the xCELLigence system (Roche Applied Science), cells were pretreated with ALLN 30 min before monitoring of the cells was started.
Transfection with skNAC-specific siRNA
Transfections were carried out using predesigned skNAC-specific siRNA (skNAC siRNA: sense, 5 -GACAGUUCCUGUUGAGA-AAUU-3 and antisense, 5 -UUUCUCAACAGGAACUGUCUU-3 ; scrambled siRNA: sense, 5 -CGUACGCGGAAUACUUC-GAUU-3 and antisense, 5 -UCGAAGUAUUCCGCGUACGUU-3 ) purchased from Sigma. C2C12 cells were transfected using the transfection reagent Interferin (Polyplus Transfection) according to the manufacturer's instructions. Using this protocol, inhibition of skNAC gene expression was 80-90 % at both the RNA and the protein level ( Figure 1A ) [8] . The specificity of this approach, particularly with respect to the effects of the skNAC gene knockdown on sarcomerogenesis, has previously been demonstrated using an independent siRNA [8] , thereby ruling out off-target effects.
Transfection with skNAC gene expression vectors
For overexpression of full-length skNAC, the plasmid pCMVskNAC [3] was used in combination with the TurboFect reagent (Fermentas) according to the manufacturer's instructions. Transfection efficiency was controlled with a GFP expression vector and was 40-50 % in all experiments.
Analysis of myoblast migration and adhesion
For quantification of cell migration and adhesion, the xCELLigence was used according to the manufacturer's instructions. Briefly, to examine cell migration, a CIM-plate 16 (Roche Applied Science) was used. The lower chambers were filled with fresh medium containing 10 % FBS or with serumfree medium. The upper chambers were filled with serum-free medium (50 μl/well) and the plate was incubated at 37
• C in 5 % CO 2 for 1 h. Background values were measured using a RTCA DP analyser. The cells (5.0×10 4 ) were added in triplicate to each well. After 30 min, the CIM-plate was assembled on to the RTCA DP analyser and cell migration was assessed at 15-min intervals for 12 h at 37
• C in 5% CO 2 . Cell migration to lower chambers was monitored and expressed as the cell migration index at 6 h and a slope was calculated using the RTCA software 1.2. For determination of cell adhesion, E plate 16 (Roche Applied Science) assemblies were seeded with cells (2.0×10 4 cells/well). Each plate was then assembled on the RTCA DP analyser and data were gathered at 1-min intervals for 3 h at 37
• C in 5% CO 2 . At least three independent experiments from three different transfections were performed.
RNA isolation, Northern blot analysis and semi-qPCR (quantitative real-time PCR)
RNA isolation and Northern blot analysis were carried out as described previously [16] . Semi-qPCR analysis was carried out using the Rotor Gene 2000 cycler (LTF). Gene expression was analysed using the GoTaq qPCR Master Mix (Promega). The primer sequences used are shown in Table 1 . In each experiment, melting curve analysis was performed to verify that a single transcript was produced. RT (reverse transcription)-qPCR relative gene expression was calculated using the comparative C T (2 − CT ) method, where expression was normalized to GAPDH (glyceraldehyde-3-phosphate dehydrogenase). Non-RT-and nontemplate controls were run for all reactions. Unless otherwise specified, data from at least three independent experiments were expressed as means + − S.E.M., n = 3-5. Significance was accepted at P < 0.05.
Immunofluorescence and Western blot analysis
Immunofluorescence and Western blot analyses and graphical statistical analysis of the data after normalization to α-tubulin were carried out as described previously [16] . For detection of skNAC, a polyclonal rabbit antiserum (J. Berkholz and B. Munz, unpublished results) was employed. For detection of MyHC (myosin heavy chain) via immunofluorescence and confocal microscopy, a mouse monoclonal antibody (clone 3-48), which recognizes the α and β chains of skeletal and cardiac myosins (1:100 dilution; Novus) was used. For sarcomeric actin immunofluorescence staining, the mouse monoclonal antibody ab 49672 (clone 5C5, Abcam) was employed. For MARCKS and calpain 1 Western blot analysis, the anti-MARCKS antibody (N-19) (sc-6454, 1:500 dilution; Santa Cruz Biotechnology), and the calpain 1 large subunit (m type) antibody #2556 (1:1000 dilution; Cell Signaling Technology) were used. All immunoblots were performed at least three times with samples from at least three independent transfections.
Calpain activity assay
Analysis of calpain activity in total cell lysates was performed using the calpain activity assay kit K240-100 from BIOvision, which is based on the cleavage of the fluorogenic peptide calpain substrate (Ac-LLY-AFC). The fluorigenic portion (AFC) of the latter releases fluorescence at a wavelength of 505 nm following excitation at 400 nm. Briefly, 10 6 cells were lysed in lysis buffer at 4
• C for 20 min. Subsequently, lysates were cleared by centrifugation (10 000 g for 1 min at 4
• C), and then incubated with substrate and reaction buffer for 60 min at 37
• C in the dark. Fluorescence emission was measured using a fluorescent plate reader (LS 55 Fluorescence Spectrometer, PerkinElmer). At least three independent measurements were performed. Data are presented as means + − S.E.M., n = 3-5. Significance was accepted at P < 0.05.
RESULTS skNAC regulates calpain 1 and 3 expression and calpain enzymatic activity
Since skNAC gene-knockdown skeletal muscle cells are characterized by disorganized sarcomere architecture [8] , and since calpain 3 is a known regulator of myofibril turnover and sarcomere organization [12] , we hypothesized that skNAC might be a regulator of calpain gene expression and/or calpain activity. To test this assumption, C2C12 myoblasts were transfected with skNAC-specific siRNAs and expression of calpain genes was analysed by qPCR, Northern and Western blot analysis, and immunofluorescence. Using this approach, we achieved an 80-90 % knockdown of skNAC gene expression in differentiating myoblasts ( Figure 1A) . In parallel, expression of the calpain 1 and, to a lesser extent, calpain 3 genes was strongly induced, whereas there was no effect on calpain 2 gene expression. At the protein level, we found induction of calpain 1 gene expression for up to 72 h after the induction of differentiation. In addition, whereas expression of the gene encoding the calpain substrate MARCKS was not regulated at the RNA level, Western blot analysis indicated lower levels of MARCKS protein in the siRNA-transfected cells, suggesting enhanced cleavage of this factor, potentially as a result of elevated calpain activity in these cells. By contrast, we found no effect on expression levels of the endogenous calpain inhibitor calpastatin in our system ( Figure 1B ). To analyse a potential correlation between calpain gene expression levels and calpain enzymatic activity in our skNAC gene-knockdown cells, we performed a fluorimetric calpain activity assay. We found that after inhibition of skNAC gene expression, calpain activity was enhanced approximately 2-fold ( Figure 1C ), indicating that skNAC is an inhibitor of calpain activity. To further confirm regulation of calpains by skNAC, we overexpressed the skNAC gene in C2C12 cells by transient transfection and analysed the expression of the three calpain genes. As shown in Figure 1(D) , as expected, calpain 1 and 3 gene expression was down-regulated in skNAC gene-overexpressing cells, whereas calpain 2 gene expression remained unchanged. These data suggest that calpains, specifically calpain 1, and to a lesser extent calpain 3, are regulated by skNAC.
Knockdown of skNAC gene expression enhances, whereas skNAC gene overexpression inhibits, myoblast migration
Calpains are known to be potent inducers of myoblast migration [13, 14] ; however, there are also reports from the same group suggesting a blockade of myoblast migration after calpain overexpression [17] . Thus, given the regulation of calpain activity by skNAC, we tested whether manipulation of skNAC gene expression affects myoblast migration. For this purpose, we employed the xCELLigence system, which allows continuous monitoring of cell migration over a period of several hours. As shown in Figure 2 (A), inhibition of skNAC gene expression, which is associated with an induction of calpain activity, indeed leads to strongly enhanced myoblast migration rates when compared with untransfected controls or cells that had been transfected with a non-specific ('scrambled') siRNA. Correspondingly, skNAC gene overexpression led to dramatically reduced migration rates. These data suggest that skNAC is an inhibitor of myoblast migration; however, we found little or even a slight inhibitory effect on cell adhesion in our skNAC siRNA-transfected cells ( Figure 2B ), suggesting that elevated calpain activity does not enhance cell attachment, despite the fact that myoblast adhesion is decreased after inhibiton of calpain enzymatic activity [14, 18] .
Calpain activity is necessary for the positive effect of the skNAC gene knockdown on myoblast migration
To test the hypothesis that the effects of skNAC on myoblast migration are mediated by calpains, we inhibited calpain activity using the inhibitor ALLN. This is a cell-permeable peptide aldehyde inhibitor of calpain 1 and, to a lesser extent, calpain 2. As shown in Figure 3 (A), after treatment with ALLN C2C12 cells formed fewer and shorter myotubes after the induction of differentiation and showed a rounded morphology. In addition, we found a lower percentage of MyHC-positive cells, resulting in a decreased differentiation index ( Figure 3A, inset) . Similar effects have already been demonstrated in C2C12 cells that overexpress the gene encoding the calpain inhibitor calpastatin [14] , or in which expression of the calpain 1 and 2 genes had been blocked using an oligonucleotide-mediated antisense strategy [18] . Furthermore, treatment with ALLN suppressed the expression of myogenic markers, such as myogenin or MyHC ( Figure 3B ). When we treated skNAC siRNA-transfected cells with ALLN, we found that myoblast migration rates were no longer elevated, but were even lower than those seen in the untransfected controls or cells that had been transfected with C2C12 myoblasts were transfected with skNAC-specific siRNAs (siRNA) and an unspecific control siRNA (scr). After induction of differentiation, expression of skNAC (A) and the three calpain (B) genes was analysed by semi-qPCR and Western blotting at the indicated time points. In addition, expression of the genes encoding the calpain substrate MARCKS and the calpain inhibitor calpastatin was analysed as indicated (B). Furthermore, calpain activity was determined using a specific fluorimetric assay (C). Finally, the skNAC gene was overexpressed in C2C12 cells and expression of the calpain 1, calpain 2 and calpain 3 genes was studied by qPCR and Western blot analysis (right-hand panels) (D). Results are means + − S.E.M., (n = 3-5) for at least three independent experiments. *P < 0.05. ctrl, control; DM, differentiation medium; pos., positive. the unspecific ('scrambled') siRNA, and were comparable with ALLN-treated scrambled siRNA-transfected cells ( Figure 3C ). These data indicate that the effects of skNAC on myoblast migration are calpain-dependent. Remarkably, treatment with ALLN had a similar inhibitory effect on the adhesion of both the control and skNAC siRNA-transfected cells ( Figure 3D ). These findings correspond to previous reports [14, 18] that suggest a decrease in myoblast attachment after inhibition of calpain enzymatic activity.
skNAC influences sarcomerogenesis via regulation of calpain gene expression
Since our previous study [8] had suggested a potential involvement of skNAC in the regulation of myofibrillogenesis and/or sarcomerogenesis, and since a specific role for calpains, particularly calpain 3, in these processes has earlier been suggested by other authors (for a review see [12] ), we speculated that skNAC depletion might block sarcomerogenesis via upregulation of calpain enzymatic activity. To test this hypothesis, C2C12 cells were again transfected with the skNAC-specific siRNA or the unspecific scrambled control siRNA, differentiated into myotubes for 96 h, and then treated with the calpain inhibitor ALLN 48 h after the induction of differentiation. Subsequently, sarcomere architecture was analysed via immunofluorescence staining for MyHC and α sarcomeric actin. As shown in Figure 4 , skNAC siRNA-transfected cells were characterized by bright MyHC and α sarcomeric actin fluorescence immediately beneath the plasma membrane and a weaker MyHC signal in the cell centre, a staining pattern indicative of defects in sarcomerogenesis which is typically seen in skNAC siRNA-transfected cells [8] . By contrast, scrambled siRNA-transfected controls showed a more homogeneous pattern of small punctuate structures known to be characteristic for newly forming sarcomeres ( [19, 20] and specifically [21] ). When siRNA-transfected cells were treated with ALLN, MyHC and α sarcomeric actin staining patterns resembled that seen in untreated (results not shown) or scrambled siRNA-transfected controls, indicating that skNAC depletion indeed perturbs ordered sarcomere formation by enhancing calpain activity ( Figure 4A ). Similar results were obtained when we treated the cells with dantrolene, an inhibitor of calcium release into the cell (results not shown). Taken together, these data suggest that skNAC influences sarcomere formation via regulation of calpain enzymatic activity.
DISCUSSION
Calpains are a family of Ca 2 + -dependent cytosolic cysteine proteases that play a role in the regulation of multiple cell functions under physiological and pathological conditions (for a review see [11] ). In striated muscle tissue, calpains specifically regulate myoblast migration and sarcomere remodelling. The mechanism by which calpains modulate myoblast migration appears to be mainly via influencing the organization of actin stress fibres, with the calpain substrate MARCKS playing a central role [13, 14, 18, 22] . In addition, calpains, specifically calpain 3, are considered to be a chef d'orchestre or 'gatekeeper' of sarcomere remodelling (for a review see [12] ).
Thus, since we have recently demonstrated that skNAC is important for the establishment and/or maintenance of sarcomere homoeostasis in mammalian myoblasts [8] , we hypothesized that this protein might control the activities of calpain and, if so, potentially also be involved in the regulation of myoblast migration.
In the present study, we demonstrate that knocking down skNAC gene expression indeed leads to up-regulation of calpain 1 and, to a lesser extent, calpain 3 gene expression, and an increase in total calpain enzymatic activity in parallel with enhanced cleavage of the calpain substrate MARCKS. Consistently, overexpression of the skNAC gene had the opposite effect, indicating that skNAC is a negative regulator of calpain gene expression.
As stated above, calpains are known to not only regulate sarcomere architecture, but also the migration and adhesion of skeletal muscle cells. Thus, given the regulation of calpains by skNAC, we hypothesized that the latter might also play a role in this process. To test this hypothesis, migration rates of skNAC gene-knockdown and skNAC gene-overexpressing cells were compared with those of control myoblasts. Interestingly, we could In addition, expression of myogenic markers was analysed using semi-qPCR and Northern blot analysis as indicated (B). Furthermore, myoblast migration (C) and adhesion (D) were determined using the xCELLigence system. The control curve (C) corresponds to the basal migration of C2C12 cells without attractant. The histograms represent a statistic quantification of the respective plots' slopes within the indicated time frames and of the cell index (migrated cells after 6 h and adhered cells after 2 h). Treatment with the ALLN solvent DMSO alone had no effect on cell morphology, migration, and adhesion (C, and results not shown). Note that the 'si + ALLN' and 'scr + ALLN' graphs in (C), as well as the 'DM' and the 'scr' graphs in (D), and the 'scr + ALLN' and the 'siRNA and ALLN' graphs in (D) almost run together. Results are means + − S.D. for a representative experiment chosen from a series of three independent experiments. ctrl, control; Mef2c, myocyte-specific enhancer factor 2C; scr, scrambled siRNA; si, siRNA; w/o, without *P < 0.05.
show that skNAC gene-deficient cells, which are characterized by enhanced calpain activities, indeed showed enhanced migration rates, whereas skNAC gene-overexpressing cells migrated more slowly than the controls. Remarkably, treatment with the calpain inhibitor ALLN blocked the enhanced migration seen after skNAC siRNA transfection, suggesting that the positive effect of skNAC knockdown on migration is indeed mediated by calpains. However, it should be mentioned that the specificity of ALLN is not unique: besides blocking the activities of calpain 1 and 2, ALLN also inhibits other neutral cysteine proteases, cathepsin B and L, and the proteasome. Thus we cannot exclude the possibility that other proteases also play a role in the mediation of the positive effect of skNAC depletion on myoblast migration. However, despite the fact that myoblast adhesion is decreased after inhibiton of calpain enzymatic activity (the present study and [14, 18] ), we did not see enhanced cell attachment in our siRNAtransfected cells when compared with the controls, indicating that for optimal cell adhesion, physiological levels of calpain activity might already be sufficient. We even observed a slight down-regulation of cell attachment, which might be due to a calpain-independent mechanism that might overpower a potential beneficial influence of the elevated calpain activities of our siRNA-transfected cells.
Besides controlling myoblast migration, the results of the present study indicate that elevated calpain activities might also be responsible for the perturbed sarcomerogenesis seen after skNAC depletion. The underlying mechanisms, however, are still largely unknown. Nevertheless, it is well known that calpain 3, at least, cleaves multiple substrates that are sarcomeric or sarcomereassociated proteins, such as titin, thereby altering the particular characteristics of these proteins, such as their interaction with other factors [12, 23] .
Since we could demonstrate that skNAC controls calpain activities, at least in part, by altering the transcript levels of the calpain 1 and 3 genes, it is most likely that the protein acts as a transcriptional co-activator here, perhaps via a chromatinmodifying mechanism. It is well known that the skNAC interaction partner m-Bop/Smyd1 harbours MYND and SET domains known to be associated with histone methyltransferase and the regulation of histone deacetylase activities. In fact, unpublished data from our laboratory indicate that skNAC is indeed a regulator of H3K4 (histone 3 methylated at Lys 4 ) histone methyltransferase activity (J. Berkholz and B. Munz, unpublished work). Thus, in the future, it will be interesting to determine whether calpain gene expression is, directly or indirectly, regulated by epigenetic mechanisms.
In addition, given the fact that elevated calpain activity after skNAC depletion was probably mainly due to enhanced transcription of the calpain 1 and 3 genes (as shown above), it is still unclear what the physiological role of the skNACmBop/SmyD1 translocation to the cytoplasm during later stages of myogenesis might be, i.e. what function these proteins might have in the cytosol, specifically in nascent sarcomeres, at that time.
In summary, these data suggest that skNAC-regulated calpain activities are crucial for the control of myoblast migration and sarcomere architecture.
Since skNAC has been implicated in the regulation of muscle fibre-type specification [3, 4] , it will be interesting to determine whether skNAC-mediated regulation of calpain activity might also play a role in this process. Interestingly, a role for calpains in the regulation of fibre-type specification and transformation has been suggested previously [24] [25] [26] [27] [28] . The underlying mechanism, however, is still largely enigmatic. A recent study suggests that at least calpain 3 might act on the CaMKII (Ca 2 + /calmodulindependent protein kinase II) pathway, which plays a role in the fast-to-slow fibre-type transformation. Moreover, patients suffering from LGMD2a, which is caused by a defective calpain 3 gene, show more severe disease involvement of slow type I fibres [29] , thus indicating a role for calpains in the white-to-red fibre-type transformation.
Finally, since calpains have been implicated in the impaired satellite cell function seen after exposure to oxidative stress [30] , and since calpains, specifically calpain 3, appear to play a role in the generation of 'reserve cells' in an in vitro model of satellite cell formation [31] , it will be interesting to determine whether the defects with respect to satellite cell survival seen in skNAC − / − mice [4] are also calpain-dependent.
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